Evidence map›Paper›PMID 35796630›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2022

Triple Regioselective Functionalization of Cationic [4]Helicenes via Iridium-Catalyzed Borylation and Suzuki Cross-Coupling Reactivity.

Lucas Frédéric, Bibiana Fabri, Laure Guénée, Francesco Zinna, Lorenzo Di Bari, Jérôme Lacour

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lucas FrédéricDepartment of Organic Chemistry, University of Geneva, Quai Ernest Ansermet 30, 1211, Geneva 4, Switzerland.ORCID http://orcid.org/0000-0002-4700-2279
Bibiana FabriDepartment of Organic Chemistry, University of Geneva, Quai Ernest Ansermet 30, 1211, Geneva 4, Switzerland.ORCID http://orcid.org/0000-0003-3466-3120
Laure GuénéeLaboratoire de Cristallographie, University of Geneva, Quai Ernest Ansermet 24, 1211, Geneva 4, Switzerland.ORCID http://orcid.org/0000-0002-2136-0510
Francesco ZinnaDipartimento di Chimica e Chimica Industriale, University of Pisa, Via G. Moruzzi 13, Pisa, Italy.ORCID http://orcid.org/0000-0002-6331-6219
Lorenzo Di BariDipartimento di Chimica e Chimica Industriale, University of Pisa, Via G. Moruzzi 13, Pisa, Italy.
Jérôme LacourDepartment of Organic Chemistry, University of Geneva, Quai Ernest Ansermet 30, 1211, Geneva 4, Switzerland.ORCID http://orcid.org/0000-0001-6247-8059
University of Geneva · CHUniversity of Pisa · IT

Funding

H2020 Marie Skłodowska-Curie Actions 859752 HEL4CHIROLEDSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 184843Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 207539
6 · The paper itself

Abstract

In essentially one-pot, using Ir- and Pd-catalysis, tris(arene)-functionalized cationic [4]helicenes are synthesized with full regioselectivity and enantiospecificity starting from a trivial precursor (17 examples). This poly-addition of aryl groups improves key optical properties, that is, fluorescence quantum yields and lifetimes. Electronic circular dichroism and circularly polarized luminescence signatures are observed up to the far-red domain, in particular with additional arenes prone to aggregation.

Indexed as

cationic heliceneschiroptical spectroscopydyes and fluorophoresIr-catalyzed borylation •late stage functionalization

Identifiers

PMID35796630
OpenAlexW4284710276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.